Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
Published July 15, 2026 · Recall initiated: June 24, 2026
Summary
FDA records drug Class II recall D-0673-2026, published July 15, 2026 and initiated June 24, 2026. Recalling firm: Reliance Life Sciences Private Limited; Status: Ongoing; Reported quantity: 11,400 vials; Lot: Lot, expiry: RBIH0125A Jan 31, 2028; RBIH0225A Feb 29, 2028; RBIH0325A Feb 29, 2028; RBIH0525A Mar 31, 2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Sterility Assurance
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Reliance Life Sciences Private Limited
- Distributor
- Nationwide in the USA
- Lot
- Lot, expiry: RBIH0125A Jan 31, 2028; RBIH0225A Feb 29, 2028; RBIH0325A Feb 29, 2028; RBIH0525A Mar 31, 2028
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAPemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only,July 15, 2026
- FDAAzacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and IntravenousJuly 15, 2026
- FDAPemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only,July 15, 2026
- FDAClomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), Net Weight a)1 KG (NDC 84849-000-01),July 15, 2026
- FDADrogueria San Juan Puerto Rico Isopropyl Alcohol 70%, 32 oz., 946 mL, Distributed by: Drogueria San Juan,July 15, 2026
- FDASmoked Sausage Spice 32.86#July 15, 2026
Questions about this recall
Was Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01 recalled?
Yes. FDA published recall D-0673-2026 on July 15, 2026. Reported hazard: Lack of Sterility Assurance
What should I do if I have this product?
Voluntary: Firm initiated · Letter